-- PanGIA Analysis System, a novel machine learning platform for non-invasive diagnosis of oral cancer through an oral sample -- PanGIA Analysis System, a novel machine learning platform for ...
PanGIA Biotech, Inc. ("PanGIA") announced a peer-reviewed clinical study published in Diagnostics, "Urine-Based Machine ...
TOBY, Inc., a biotechnology company developing non-invasive cancer screening technologies, today announced that the U.S. Food ...
Former Castle Biosciences SVP brings proven diagnostic commercialization and reimbursement leadership to NovaScan’s ...
Irvine-based Helio Genomics announces partnership with Quest Diagnostics to distribute its liver cancer detection test ...
Harbinger Health, a Cambridge biotech spun out of Flagship, says it has locked in $100 million in new financing as it races ...
A machine learning model that analyzes patient demographics, electronic health record data, and routine blood test results predicted a patient's risk of hepatocellular carcinoma (HCC), the most common ...
Final random-forest-based models outperformed all publicly available risk scores on internal and external test sets.
{image id=1352663 align=left size=large byline=true caption="The Massachusetts General Hospital, home to Mass Eye and Ear and part of the Mass General Brigham system ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results